← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 25, 2018Last known activity
Dec 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (14)
- NCT07262723Lead sponsorPhase 2/Phase 3Dec 1, 2025
- NCT07262723Sponsor investigatorPhase 2/Phase 3Dec 1, 2025
- NCT06502288OfficialN/AJan 1, 2025
- NCT06918405Lead sponsorPhase 3Jan 1, 2025
- NCT06918405Sponsor investigatorPhase 3Jan 1, 2025
- NCT06502288Sponsor investigatorN/AJan 1, 2025
- NCT06502288Lead sponsorN/AJan 1, 2025
- NCT06847139Lead sponsorN/AJul 1, 2024
- NCT06847139Sponsor investigatorN/AJul 1, 2024
- NCT04332068CollaboratorPhase 2Nov 1, 2020
- NCT04977557Reponsible party - principal investigatorN/ANov 11, 2018
- NCT04977557Lead sponsorN/ANov 11, 2018
- NCT04205201Reponsible party - principal investigatorPhase 2Jun 25, 2018
- NCT04205201Lead sponsorPhase 2Jun 25, 2018
Details
- Last known activity
- Dec 1, 2025